Aclarion Operating Margin from 2010 to 2024

ACON Stock  USD 0.18  0.01  5.88%   
Aclarion Operating Profit Margin yearly trend continues to be very stable with very little volatility. Operating Profit Margin is likely to drop to -67.9.
Check Aclarion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aclarion's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 139.1 K or Interest Expense of 605.7 K, as well as many indicators such as Price To Sales Ratio of 22.45, Dividend Yield of 0.096 or Days Sales Outstanding of 128. Aclarion financial statements analysis is a perfect complement when working with Aclarion Valuation or Volatility modules.
  
Check out the analysis of Aclarion Correlation against competitors.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.

Latest Aclarion's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Aclarion over the last few years. It is Aclarion's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aclarion's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (103.51) %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Aclarion Operating Margin Regression Statistics

Arithmetic Mean(124.44)
Coefficient Of Variation(30.53)
Mean Deviation33.03
Median(149.21)
Standard Deviation37.99
Sample Variance1,443
Range100
R-Value0.79
Mean Square Error572.35
R-Squared0.63
Significance0.0004
Slope6.75
Total Sum of Squares20,205

Aclarion Operating Margin History

2024 -67.9
2023 -64.66
2022 -100.9
2021 -48.98
2020 -92.03

About Aclarion Financial Statements

Aclarion investors utilize fundamental indicators, such as Operating Margin, to predict how Aclarion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports:
Check out the analysis of Aclarion Correlation against competitors.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.40)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.36)
Return On Assets
(1.15)
Return On Equity
(7.14)
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.